ChemicalBook >?? ???? >(5ALPHA,6BETA)-17-(CYCLOPROPYLMETHYL)-4,5-EPOXY-MORPHINAN-3,6,14-TRIOL HYDRATE

(5ALPHA,6BETA)-17-(CYCLOPROPYLMETHYL)-4,5-EPOXY-MORPHINAN-3,6,14-TRIOL HYDRATE

(5ALPHA,6BETA)-17-(CYCLOPROPYLMETHYL)-4,5-EPOXY-MORPHINAN-3,6,14-TRIOL HYDRATE ??? ???

?? ??:

???:: (5ALPHA,6BETA)-17-(CYCLOPROPYLMETHYL)-4,5-EPOXY-MORPHINAN-3,6,14-TRIOL HYDRATE

???(??):: 6β-Naltrexol hydrate;6BETA-NALTREXOL HYDRATE;(5α,6β)-17-(Cyclopropylmethyl)-4,5-epoxy-morphinan-3,6,14-triol hydrate;(5ALPHA,6BETA)-17-(CYCLOPROPYLMETHYL)-4,5-EPOXY-MORPHINAN-3,6,14-TRIOL HYDRATE

CBNumber:: CB2456683

???:: C20H27NO5

??? ??:: 361.43

MOL ??:: Mol file

?? ?? 2

(5ALPHA,6BETA)-17-(CYCLOPROPYLMETHYL)-4,5-EPOXY-MORPHINAN-3,6,14-TRIOL HYDRATE ??

?? ??: 2-8°C

???: DMSO: ~12mg/mL

??? ??: ??

??: ???

??

WGK ??	3

(5ALPHA,6BETA)-17-(CYCLOPROPYLMETHYL)-4,5-EPOXY-MORPHINAN-3,6,14-TRIOL HYDRATE C??? ??, ??, ??

Biochem/physiol Actions

Neutral antagonist of the μ-opioid receptor. A reduction of withdrawal effects associated with neutral μ-opioid receptor antagonists may offer advantages in treating opioid overdose and addiction.

(5ALPHA,6BETA)-17-(CYCLOPROPYLMETHYL)-4,5-EPOXY-MORPHINAN-3,6,14-TRIOL HYDRATE ?? ?? ? ???

???

?? ??

(5ALPHA,6BETA)-17-(CYCLOPROPYLMETHYL)-4,5-EPOXY-MORPHINAN-3,6,14-TRIOL HYDRATE ?? ??

???( 2)?? ??

???	??	???	??	?? ?	??
Riedel-de Haen AG	--		United States	6773	87
SIGMA-RBI	--		Switzerland	6896	91

午夜插插,噜噜噜影院,啪啪伊人网,欧美熟夫,景甜吻戏视频,男人强操性感蕾丝美女视频在线网站,日本美女跳舞视频